Del Campo Campos, CristinaBai, JiaruKeller,L. Robin2025-05-262025-05-262025-06-01del Campo, C., Bai, J., & Keller, L. R. (2025). Modeling cost-effectiveness analysis of treatment sequencing. Socio-Economic Planning Sciences, 99, 102210.0038-012110.1016/j.seps.2025.102210https://hdl.handle.net/20.500.14352/120473In clinical practice, patients with cancer often undergo treatment with a sequence of drugs, usually because of diminishing effectiveness over time or resistance development. However, few cost-effectiveness analyses have included that fact in their model. This paper aims at closing that gap by presenting a model that reflects the possibility of the patient switching from one therapeutic agent to another one throughout the long-term duration of his/her life.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/journal article1873-6041https://doi.org/10.1016/j.seps.2025.102210https://www.sciencedirect.com/science/article/pii/S003801212500059Xopen accessDecision analysisTreatment sequencingMultiple lines of treatmentMarkov modelCost-effectiveness analysisTeoría de la decisiónPlanificación económica1209.04 Teoría y Proceso de decisión1208.06 Procesos de Markov